Patients with NAFLD were characterized by significantly (Table 1) higher serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) activities as compared to patients without NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.